Alpha-Fetoprotein, Tumor Marker
- Laboratory
- Quest Diagnostics
- Test code
- 237
- Specimen
- Serum
- Fasting
- Not stated
- LOINC
- 53962-7
- Turnaround
- Set up: Mon-Fri; Report available: 5 days
Laboratory assay overview
Elevation of serum AFP above values found in healthy individuals occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. AFP is not recommended as a screening procedure to detect cancer in the general population.
Quest Diagnostics population reference ranges
Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.
| Population | Range |
|---|---|
| Provider context | Male (ng/mL) | Female (ng/mL) |
| <1 Month* | 0.5-16387.0 | 0.5-18964.0 |
| 1-11 Months | 0.5-28.3 | 0.5-77.0 |
| 1-3 Years | 0.5-7.9 | 0.5-11.1 |
| >3 Years | <6.1 | <6.1 |
View complete laboratory reference notes
Male (ng/mL) Female (ng/mL) <1 Month* 0.5-16387.0 0.5-18964.0 1-11 Months 0.5-28.3 0.5-77.0 1-3 Years 0.5-7.9 0.5-11.1 >3 Years <6.1 <6.1 *Pediatric range is based on full term neonates, values for premature infants may be higher. The use of AFP as a tumor marker in pregnant females is not recommended.
Quest Diagnostics test directory, test code 237